Investor Relations

Latest News

Apr 5, 2021

DiaMedica Therapeutics to Present Research at the National Kidney Foundation’s 2021 Spring Clinical Meetings

View Press Release

Mar 10, 2021

DiaMedica Therapeutics Announces 2020 Financial Results and Provides a Business Update

Mar 10, 2021

DiaMedica Therapeutics to Present Research at International Stroke Virtual Conference

View All News

DM199 KOL Event Presentation

View Presentation

Apr 28 – Apr 29, 2021

B. Riley Neuroscience Conference

View All

Jun 2, 2021 8:00 am EDT

18th Annual Craig-Hallum Institutional Investor Conference

Add to Calendar View All

Nov 2 – Nov 7, 2021

ASN Kidney Week 2021

View All

Company Overview

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company developing recombinant proteins to improve the lives of patients who experience a stroke or recurrent strokes and kidney diseases.

View Board of Directors

Investor Contact Information

Company

DiaMedica Therapeutics, Inc.
Two Carlson Parkway,
Suite 260
Minneapolis, MN 55447